Expanding Market Reach Torigen is actively expanding its distribution network with partnerships such as MWI Animal Health and a preferred partnership with VerticalVet, which provides access to over 2,000 veterinary clinics. This broadened reach presents substantial sales opportunities for veterinary suppliers and distributors interested in innovative cancer treatments.

Innovative Treatment Solutions The company’s focus on personalized cancer vaccines using pet-specific tumor cells positions it as a pioneer in veterinary oncology. Veterinary clinics seeking cutting-edge, biologics-based treatments represent potential clients looking to differentiate their services and offer advanced therapies.

Recent Technological Expansion With the launch of a new Specialty Pathology Service and recent expansion of their facilities in Farmington, Torigen demonstrates growth in diagnostic capabilities and production capacity. This enables them to meet increasing demand and provides opportunities for sales of diagnostic and biologic products.

Funding and Financial Growth Having secured $13 million in Series A funding and expanded their operations, Torigen is positioning itself for growth within the veterinary biologics market. Sales efforts can target veterinary practices and clinics interested in partnering with financially backed innovators with promising market potential.

Strategic Collaborations Partnerships with prominent organizations such as Premier Vet and VerticalVet, alongside distribution agreements with MWI, create multiple channels for product dissemination. These partnerships open doors for sales collaborations, co-marketing opportunities, and referral networks among veterinary practitioners.